Previous 10 |
Zymergen (ZY) has priced its upsized IPO of 16.13M common shares (from 13.6M) at $31.00/share, for expected gross proceeds of ~$500MUnderwriters' over-allotment is an additional ~2.42M shares.Trading kicks off April 22.Closing date is April 26. J.P. Morgan and Goldman Sachs are lead book-runn...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif. , Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced t...